ISS, Inc.: Clinical Trials

3 trials sponsored by ISS, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated. 1 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Recruiting 1
Phase 21Terminated 1
Phase 31Completed 1

Follow ISS, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes
Apomorphine Cartridge - Parkinson Disease
Phase 2TerminatedAlexza Pharmaceuticals, Inc.82023-09-272025-10-21
Optimized MRI of Patients With Hip Arthroplasty
Modified MRI - Hip Arthropathy
Not applicableRecruitingNYU Langone Health222022-08-112026-03-04
Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers
OxiplexTS - Obstructive Sleep Apnea Syndrome
Phase 3CompletedISS, Inc.3092007-08-012011-03-16

Conditions studied

Microcephaly, Primary Autosomal Recessive, 6 (1)  ·  Parkinson Disease (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Apnea, Obstructive (1)

Countries

United States (3)

Top investigators

Antonios Michalos, M.D., M.S. (1)  ·  Iman Khodarahmi, MD (1)

NIH funding

R44NS040597 (1)